The M72/AS01E vaccine candidate launched in 2024 almost after a century of BCG vaccine discovery is effective against which of the following diseases?
AMalaria
BCOVID-19
CHIV
DTuberculosis
Answer:
D. Tuberculosis
Read Explanation:
The M72/AS01E vaccine candidate, launched in 2024, is designed to prevent tuberculosis (TB) disease, specifically active pulmonary TB, in adults with latent Mycobacterium tuberculosis (Mtb) infection.
M72/AS01E is an experimental tuberculosis vaccine. If approved, it would be the first vaccine for tuberculosis in more than a century after the BCG vaccine